Literature DB >> 15463826

Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers.

L P A McGarvey1, K Dunbar, S L Martin, V Brown, J Macmahon, M Ennis, J S Elborn.   

Abstract

BACKGROUND: Induced sputum (IS) has been proposed as a non-invasive alternative to bronchoalveolar lavage (BAL) for the assessment and monitoring of airways inflammation. The aim of this study was to compare both methods in patients with cystic fibrosis (CF). The possible differences between subjects with CF, mild asthma and healthy volunteers (HV) was also assessed.
METHOD: In a single centre, randomised, two way crossover study, 11 patients with CF, 9 mild asthmatics (MA) and 11 HV underwent BAL and hypertonic saline induction on consecutive days. Free neutrophil elastase (NE), neutrophil elastase/alpha(1)-anti-trypsin complex (NE-AAT), tumour necrosis factor receptor (p55) and interleukin-8 (IL-8) were measured in cell free supernatants.
RESULTS: Three CF patients reported serious adverse events following BAL. NE was usually undetectable in both IS or BAL samples and NE-AAT concentrations did not differ consistently between the two sampling methods. IL-8 and p55 levels in the CF patients tended to be higher in IS samples compared with BAL samples (median 19,860 vs. 3,855 pg/ml and 2.55 vs. 0.29 ng/ml, respectively). There was a significant difference in mean p55 concentrations between CF, MA and HV in IS samples (P=0.003) but not in BAL samples (P=0.36). The difference in mean IL-8 concentrations in IS samples between subject groups was statistically different (P=0.023).
CONCLUSIONS: IS samples can be safely obtained from CF patients. Analysis of IS samples can help to characterize the inflammatory process in the airways of CF patients. The serious adverse events following BAL in 3 CF patients highlight an inherent risk associated with this procedure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15463826     DOI: 10.1016/s1569-1993(02)00098-x

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  12 in total

1.  Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1.

Authors:  N Dauletbaev; K Herscovitch; M Das; H Chen; J Bernier; E Matouk; J Bérubé; S Rousseau; L C Lands
Journal:  Br J Pharmacol       Date:  2015-10       Impact factor: 8.739

2.  Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms.

Authors:  Nurlan Dauletbaev; Daniel Eklove; Nadir Mawji; Michele Iskandar; Sergio Di Marco; Imed-Eddine Gallouzi; Larry C Lands
Journal:  J Biol Chem       Date:  2011-03-15       Impact factor: 5.157

3.  Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease.

Authors:  Jerry M Wright; Christian A Merlo; Jeffrey B Reynolds; Pamela L Zeitlin; Joe G N Garcia; William B Guggino; Michael P Boyle
Journal:  Am J Respir Cell Mol Biol       Date:  2006-04-13       Impact factor: 6.914

4.  Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.

Authors:  Geraint B Rogers; Stuart Skelton; David J Serisier; Christopher J van der Gast; Kenneth D Bruce
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

Review 5.  Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset.

Authors:  Geraint B Rogers; Lucas R Hoffman; Matt W Johnson; Nicole Mayer-Hamblett; Jürgen Schwarze; Mary P Carroll; Kenneth D Bruce
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

Review 6.  CFTR activity and mitochondrial function.

Authors:  Angel Gabriel Valdivieso; Tomás A Santa-Coloma
Journal:  Redox Biol       Date:  2013-02-05       Impact factor: 11.799

7.  Biomarkers of inflammation in infants with cystic fibrosis.

Authors:  Theresa A Laguna; Cynthia B Williams; Myra G Nunez; Cole Welchlin-Bradford; Catherine E Moen; Cavan S Reilly; Chris H Wendt
Journal:  Respir Res       Date:  2018-01-08

Review 8.  Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.

Authors:  Aidan Bannon; Shu-Dong Zhang; Bettina C Schock; Madeleine Ennis
Journal:  Med Princ Pract       Date:  2015-04-25       Impact factor: 1.927

Review 9.  Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.

Authors:  Kamini Jain; Claire Wainwright; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2018-09-17

10.  Lung Defense through IL-8 Carries a Cost of Chronic Lung Remodeling and Impaired Function.

Authors:  Catherine J Reynolds; Kathryn Quigley; Xiaoming Cheng; Apurva Suresh; Sundas Tahir; Fiyyaz Ahmed-Jushuf; Khizr Nawab; Katherine Choy; Simone Alexandra Walker; Sara A Mathie; Malcolm Sim; Janet Stowell; Jiten Manji; Tracey Pollard; Daniel M Altmann; Rosemary J Boyton
Journal:  Am J Respir Cell Mol Biol       Date:  2018-11       Impact factor: 7.748

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.